| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000035719 |
| Receipt No. | R000040307 |
| Scientific Title | Verification of the effect of skin function improvement by intake of lactic acid bacteria. |
| Date of disclosure of the study information | 2020/01/30 |
| Last modified on | 2020/01/31 (Ver. 3) |
| Basic information | ||
| Public title | Verification of the effect of skin function improvement by intake of lactic acid bacteria. | |
| Acronym | Verification of the effect of skin function improvement. | |
| Scientific Title | Verification of the effect of skin function improvement by intake of lactic acid bacteria. | |
| Scientific Title:Acronym | Verification of the effect of skin function improvement. | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adults | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | Verification of the effect of skin function improvement by intake of lactic acid bacteria. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Changes in skin function before ingestion and after ingestion period |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Test food: ingestion of food containing lactic acid bacteria
1 cupsule/day, 8 weeks |
|
| Interventions/Control_2 | Pracebo food: ingestion of food not containing lactic acid bacteria
1 cupsule/day, 8 weeks |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Japanese men and women aged 35 to 59 years old at the time of acquiring consent
2) Persons who care about dry skin 3) Persons who feel sagging skin 4) Persons who are aware of rough skin 5) Persons who are aware of rough skin due to drying, etc. on either the right cheek, the right neck, the upper back, the right shank, the right foot back, or the left cheek, or who have itching symptoms (it is desirable when there is desquamation), or who have flaky skin after bathing, every year from October to March 6) Persons who can stop drinking alcohols from the day before the observation date until the end of the measurement on the observation day 7) Persons who received a sufficient explanation of the purpose of this exam, have the capacity to consent, volunteer for participation after understanding well, and who agreed in writing to participate in this study 8) Persons with stains on their right cheek |
|||
| Key exclusion criteria | 1) Persons who are judged inappropriate by the examining supervisor or doctor in charge of examination
2) Persons with chronic skin symptoms such as atopic dermatitis 3) Persons who used cosmetics containing hyaluronic acid, collagen, ceramide, vitamins etc. within 1 month before start of use 4) Persons who ingested supplements containing hyaluronic acid, collagen, ceramide, vitamins etc. within 1 month before start of use 5) Persons taking or planning to take medicine with hay fever 6) Persons who currently go to dermatology department 7) Persons participating in a test taking other foods or medicines, or applying cosmetics and medicines etc, or participated in similar exams in less than 3 months 8) Persons participating in other clinical trials 9) During pregnancy or planned, or those who are breastfeeding 10) Persons who may have an allergy such as having a history of hypersensitivity to the test article 11) Persons who are likely to have allergic symptoms depending on the test article components 12) Persons with significant abnormalities in the skin condition of the test site (cheek, upper back, neck, elbow, paw) 13) Persons who have chronic illness and regularly use medication 14) Persons who have athema 15) Persons with soy allergy |
|||
| Target sample size | 80 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Shiba Palace Clinic | ||||||
| Division name | Chair | ||||||
| Zip code | 1050013 | ||||||
| Address | 6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan | ||||||
| TEL | 03-5408-1590 | ||||||
| jimukyoku@mail.souken-r.com | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | SOUKEN Co., Ltd | ||||||
| Division name | Management Division | ||||||
| Zip code | 1050013 | ||||||
| Address | 3F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan | ||||||
| TEL | 03-5408-1555 | ||||||
| Homepage URL | |||||||
| k_masuda@mail.souken-r.com | |||||||
| Sponsor | |
| Institute | Shiba Palace Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | NISSIN FOODS HOLDINGS CO.,LTD |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Shiba Palace Clinic Ethics Review Committee |
| Address | 6F DaiwaA Hamamatucho Bld., 1-9-10 Hamamatsucho, Minato-ku, Tokyo, 105-0013, Japan |
| Tel | 03-5408-1590 |
| jimukyoku@mail.souken-r.com | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB | |||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000040307 |